- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
52 Week Highs
Back to dashboard| Company Name | Symbol | Price | Prev. Close | Volume | 1 Year (%) |
|---|---|---|---|---|---|
| Enerflex Ltd Common Shares | EFXT | 22.61 | 22.64 | 248,620 | +14.78 (188.76%) |
| Fate Therapeutics, Inc. - Common Stock | FATE | 3.059 | 2.990 | 1,773,299 | +2.00 (188.63%) |
| uniQure N.V. - Ordinary Shares | QURE | 41.17 | 41.36 | 1,323,892 | +26.86 (187.70%) |
| Crinetics Pharmaceuticals, Inc. - Common Stock | CRNX | 83.47 | 42.03 | 71,965,998 | +54.41 (187.25%) |
| Anteris Technologies Global Corp. - Common Stock | AVR | 9.985 | 10.57 | 671,744 | +6.50 (186.93%) |
| Applied Materials | AMAT | 546.99 | 592.79 | 8,335,699 | +356.21 (186.71%) |
| Electrovaya Inc. - Common Shares | ELVA | 9.085 | 9.670 | 364,581 | +5.91 (185.69%) |
| Tradr 2X Long BE Daily ETF | BEX | 45.31 | 55.57 | 1,533,532 | +29.45 (185.69%) |
| Esperion Therapeutics, Inc. - Common Stock | ESPR | 3.165 | 3.150 | 6,131,523 | +2.05 (185.14%) |
| Stoke Therapeutics, Inc. - Common Stock | STOK | 33.29 | 32.43 | 570,551 | +21.60 (184.77%) |
| Immunome, Inc. - Common Stock | IMNM | 24.74 | 23.90 | 992,758 | +16.05 (184.70%) |
| UroGen Pharma Ltd. - Ordinary Shares | URGN | 38.34 | 37.41 | 562,101 | +24.85 (184.25%) |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 12.63 | 12.77 | 989,269 | +8.18 (183.82%) |
| Taysha Gene Therapies, Inc. - Common Stock | TSHA | 6.625 | 6.380 | 1,698,998 | +4.29 (183.12%) |
| Tradr 2X Long GEV Daily ETF | GEVX | 23.53 | 27.44 | 484,211 | +15.20 (182.41%) |
| Sterling Infrastructure, Inc. - Common Stock | STRL | 669.18 | 717.11 | 430,779 | +432.18 (182.35%) |
| C4 Therapeutics, Inc. - Common Stock | CCCC | 4.290 | 4.140 | 2,948,971 | +2.77 (182.24%) |
| NETCLASS TECHNOLOGY INC - Class A Ordinary Shares | NTCL | 4.205 | 4.620 | 50,371 | +2.71 (182.21%) |
| Protagonist Therapeutics, Inc. - Common Stock | PTGX | 140.66 | 131.50 | 897,714 | +90.79 (182.05%) |
| Onto Innovation Inc. Common Stock | ONTO | 278.23 | 303.86 | 937,636 | +179.53 (181.89%) |
| InnovAge Holding Corp. - Common Stock | INNV | 11.75 | 12.11 | 195,518 | +7.58 (181.77%) |
| Tilly's, Inc. Common Stock | TLYS | 4.190 | 4.300 | 93,347 | +2.70 (181.21%) |
| Tharimmune, Inc. - Common Stock | THAR | 4.740 | 4.740 | 0 | +3.05 (180.46%) |
| Zenas BioPharma, Inc. - Common Stock | ZBIO | 27.43 | 26.45 | 390,586 | +17.64 (180.13%) |
| Tetra Technologies, Inc. Common Stock | TTI | 9.050 | 9.400 | 776,541 | +5.81 (179.32%) |
| Ligand Pharmaceuticals Incorporated - Common Stock | LGND | 316.97 | 320.42 | 201,187 | +203.21 (178.63%) |
| Nuvation Bio Inc. Class A Common Stock | NUVB | 5.790 | 5.600 | 4,648,501 | +3.71 (178.37%) |
| Astronics Corporation - Common Stock | ATRO | 70.61 | 71.79 | 611,216 | +45.16 (177.50%) |
| Xometry, Inc. - Class A Common Stock | XMTR | 93.43 | 94.29 | 256,132 | +59.74 (177.32%) |
| Surrozen, Inc. - Common Stock | SRZN | 23.05 | 23.66 | 128,339 | +14.70 (176.05%) |
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.